Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-05-04, Stock:ABBV, The news for the past five days is as follows:
2018-04-27: NEWS1: 9 Highest-Yielding Dividend Aristocrats to Buy Today.NEWS2: 9 Highest-Yielding Dividend Aristocrats to Buy Today.NEWS3: HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates?.NEWS4: HIV Segment to Aid Gilead (GILD) Beat Q1 Earnings Estimates?.NEWS5: 3 Things You Need to Know About AbbVie's Monster Q1 Earnings.NEWS6: 3 Things You Need to Know About AbbVie's Monster Q1 Earnings.NEWS7: 3 Things You Need to Know About AbbVie&apos;s Monster Q1 Earnings.NEWS8: AbbVie Presents New Investigational Data for Elagolix at the 2018 American College of Obstetricians and Gynecologists (ACOG) Annual Meeting.NEWS9: AbbVie Presents New Investigational Data For Elagolix.NEWS10: AbbVie Presents New Investigational Data For Elagolix.NEWS11: Edited Transcript of ABBV earnings conference call or presentation 26-Apr-18 1:00pm GMT.
2018-04-30: NEWS1: The Good and the Bad News With Biogen Inc Earnings Results.NEWS2: The Good and the Bad News With Biogen Inc Earnings Results.NEWS3: Gilead (GILD) 1st Quarter Earnings: What to Expect.NEWS4: Gilead (GILD) 1st Quarter Earnings: What to Expect.NEWS5: Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More.NEWS6: Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More.NEWS7: AbbVie and Rice University establish K.C. Nicolaou Research Accelerator to advance therapies in oncology.NEWS8: Drug Stocks Q1 Earnings to Watch on May 1: PFE, MRK & More.NEWS9: Eliquis and Xeljanz: Key Growth Drivers for Pfizer in 2018.
2018-05-01: NEWS1: Why Nutrisystem, Tenet Healthcare, and AbbVie Jumped Today.NEWS2: Why Nutrisystem, Tenet Healthcare, and AbbVie Jumped Today.NEWS3: Seagate, Pfizer and Cummins skid while AbbVie jumps.NEWS4: Why Nutrisystem, Tenet Healthcare, and AbbVie Jumped Today.NEWS5: AbbVie’s Hepatitis C Franchise, Kaletra, and Synagis in 1Q18.NEWS6: MARKETS: Stocks are selling off on the ISM miss, which also reveals problems in the factory sector.NEWS7: AbbVie’s Humira and Imbruvica: 1Q18 Performance.NEWS8: How AbbVie Fared in 1Q18.NEWS9: How AbbVie Makes its Money.NEWS10: Pre-Market Most Active for May 1, 2018 :  BP, TVIX, QQQ, SNE, SHOP, AAPL, ABBV, UAA, KLXI, UA, AVXS, SQQQ.NEWS11: Pre-Market Most Active for May 1, 2018 :  BP, TVIX, QQQ, SNE, SHOP, AAPL, ABBV, UAA, KLXI, UA, AVXS, SQQQ.NEWS12: AbbVie Submits Marketing Authorization Application to the European Medicines Agency for Investigational Treatment Risankizumab for Moderate to Severe Plaque Psoriasis.NEWS13: AbbVie Commences Self-Tender Offer for Up to $7.5 Billion of its Common Stock.NEWS14: [$$] Gilead shares rattled by sharp slide in hepatitis C drug sales.
2018-05-02: NEWS1: Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much.NEWS2: Seattle Genetics Accelerates Revenue Growth, Earnings Not So Much.NEWS3: &quot;Fast Money&quot; final trades: SNAP, SPOT and more.NEWS4: Top 4 Marijuana Stocks to Watch.NEWS5: 9 Winning Stocks as the Bull Loses Steam.NEWS6: Gilead (GILD) Q1 Earnings & Sales Miss Estimates on Weak HCV.NEWS7: Gilead (GILD) Q1 Earnings & Sales Miss Estimates on Weak HCV.NEWS8: Analyst Recommendations for AbbVie in April.NEWS9: AbbVie to Present at the 2018 Bank of America Merrill Lynch Health Care Conference.NEWS10: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS11: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS12: Better Buy: Johnson & Johnson (JNJ) vs. AbbVie (ABBV).NEWS13: Gilead Sciences&apos; First-Quarter Twist: Weak HIV Sales.
2018-05-03: NEWS1: Top 5 Biotech Stocks for 2018.NEWS2: Did Gilead Sciences Make a Big Mistake?.NEWS3: Did Gilead Sciences Make a Big Mistake?.NEWS4: Did Gilead Sciences Make a Big Mistake?.NEWS5: NBIX: Strong INGREZZA® Sales Continue in 1Q18; Expanding Sales Team for Future Growth.NEWS6: Drugmakers eye a new threat to sales but say it hasn’t affected them — yet.NEWS7: Drugmakers eye a new threat to sales but say it hasn’t affected them — yet.NEWS8: Your first trade for Thursday, May 3.NEWS9: Your first trade for Thursday, May 3.

Answer: Decrease